2
Clinical Trials associated with Recombinant Zoster Vaccine(CHO Cell)(Patronus Biotech)A Phase I, Randomized, Observer-blinded, Parallel-Controlled, Dose Escalation Clinical Trial to Assess the Safety and Immunogenicity of the Recombinant Zoster Vaccine, LYB004 in Adults Aged 40 Years and Older
This phase 1 study in China will evaluate the safety and immunogenicity of the Recombinant Zoster Vaccine, LYB004 in adults aged 40 years and older.
/ Active, not recruitingPhase 1 A Phase I, Randomized, Observer-blinded, Positive-Controlled, Dose Escalation Clinical Trial to Assess the Safety and Immunogenicity of the Recombinant Zoster Vaccine (CHO Cell), LYB004 in Adults Aged 50 to 70 Years
This phase 1 study in Australia will evaluate the safety and immunogenicity of the Recombinant Zoster Vaccine (CHO Cell), LYB004 in Adults Aged 50 to 70 Years.
100 Clinical Results associated with Recombinant Zoster Vaccine(CHO Cell)(Patronus Biotech)
100 Translational Medicine associated with Recombinant Zoster Vaccine(CHO Cell)(Patronus Biotech)
100 Patents (Medical) associated with Recombinant Zoster Vaccine(CHO Cell)(Patronus Biotech)
100 Deals associated with Recombinant Zoster Vaccine(CHO Cell)(Patronus Biotech)